Researchers have identified and characterized a new type of RNA protein called THOR that plays a role in cancer development — and could serve as a target for drug development.
Nicole Fawcett is the manager of cancer communication for the University of Michigan Rogel Cancer Center, overseeing media relations, marketing, web, internal communication, social media and publications for the center’s research and clinical enterprises. She leads a team of four communicators who produce targeted, innovative communication to meet the Cancer Center’s goals. Nicole joined Michigan Medicine in 2003. Prior to that, she was at the Detroit News and at a startup web-based community for people with disabilities.
After defining the scope of sexual harassment in medicine, a physician says sharing stories and a national reckoning offer hope for progress.
Cancer can damage undifferentiated naive T cells, which keeps the fighter cells from doing their job.
Steady rates of recurrence in women with estrogen receptor-positive disease could influence decisions about long-term therapy.
Suppressive Treg cells become even more suppressive when they die, a new study finds.
More treatment options, targeted therapies and an understanding of when less is more have improved breast cancer outcomes in recent years. But more work remains.